<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a 49-year-old woman with <z:e sem="disease" ids="C0027873" disease_type="Disease or Syndrome" abbrv="">neuromyelitis optica</z:e> (<z:chebi fb="0" ids="52093">NMO</z:chebi>) spectrum disorder coexisting with <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sj√∂gren's syndrome</z:e> (SS) </plain></SENT>
<SENT sid="1" pm="."><plain>She presented with <z:hpo ids='HP_0011009'>acute</z:hpo> brainstem symptoms and <z:e sem="disease" ids="C0026976" disease_type="Disease or Syndrome" abbrv="">transverse myelitis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Brain MRI showed focal high signal intensity lesions in the hypothalamus and the pontine tegmentum on T2-weighted and FLAIR images </plain></SENT>
<SENT sid="3" pm="."><plain>MRA revealed stenotic changes of the bilateral middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>), posterior cerebral arteries (<z:chebi fb="20" ids="36751">PCA</z:chebi>) and basilar artery (BA) </plain></SENT>
<SENT sid="4" pm="."><plain>Spinal MRI revealed hyperintense lesions within the cord extending from the T4 to the T6 level on the T2-weighted image </plain></SENT>
<SENT sid="5" pm="."><plain>The patient fulfilled the clinical criteria of primary SS </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, anti-AQP4 antibody which is highly specific for <z:chebi fb="0" ids="52093">NMO</z:chebi> was detected in the serum at the <z:hpo ids='HP_0011009'>acute</z:hpo> phase </plain></SENT>
<SENT sid="7" pm="."><plain>The patient excellently responded to IVIg while <z:chebi fb="0" ids="6888">methylprednisolon</z:chebi> pulse therapy was not effective </plain></SENT>
<SENT sid="8" pm="."><plain>Follow-up MRA displayed complete resolution of the stenosis of the <z:chebi fb="70" ids="34342">MCA</z:chebi>, <z:chebi fb="20" ids="36751">PCA</z:chebi> and BA </plain></SENT>
</text></document>